These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9018033)

  • 1. Effects of HIV seropositivity and drug abuse on cognitive function.
    Grassi MP; Perin C; Clerici F; Zocchetti C; Borella M; Cargnel A; Mangoni A
    Eur Neurol; 1997; 37(1):48-52. PubMed ID: 9018033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of the Dementia Rating Scale as a test for neuropsychological dysfunction in HIV-positive i.v. drug abusers.
    Kovner R; Lazar JW; Lesser M; Perecman E; Kaplan MH; Hainline B; Napolitano B
    J Subst Abuse Treat; 1992; 9(2):133-7. PubMed ID: 1512802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Edinburgh cohort of HIV-positive drug users: pattern of cognitive impairment in relation to progression of disease.
    Egan V; Brettle RP; Goodwin GM
    Br J Psychiatry; 1992 Oct; 161():522-31. PubMed ID: 1393340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychological differences but comparable regional cerebral blood changes in asymptomatic HIV-1-positive and -negative drug addicts.
    Beldarrain MG; García-Moncó JC; Llorens V; Cortés J; Mayo J
    Eur Neurol; 1994; 34(4):193-8. PubMed ID: 8082677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cognition disorders in HIV infection. Validation of a brief neuropsychological evaluation battery].
    Desi M; Seibel N; Korezlioglu J; Silvestre D; Linard F
    Encephale; 1995; 21(4):289-94. PubMed ID: 7588168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed recognition memory span in HIV-1 infection.
    Martin EM; Pitrak DL; Pursell KJ; Mullane KM; Novak RM
    J Int Neuropsychol Soc; 1995 Nov; 1(6):575-80. PubMed ID: 9375245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychological findings and psychiatric symptoms in HIV-1 infected and noninfected drug users.
    Pakesch G; Loimer N; Grünberger J; Pfersmann D; Linzmayer L; Mayerhofer S
    Psychiatry Res; 1992 Feb; 41(2):163-77. PubMed ID: 1574543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropsychological deficits in HIV-1 seropositive and seronegative intravenous drug users (IVDUs): a follow-up study.
    Hestad K; Aukrust P; Ellertsen B; Kløve H
    J Int Neuropsychol Soc; 1996 Mar; 2(2):126-33. PubMed ID: 9375197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early neuropsychological impairment in HIV-seropositive intravenous drug users: evidence from the Italian Multicentre Neuropsychological HIV Study.
    Starace F; Baldassarre C; Biancolilli V; Fea M; Serpelloni G; Bartoli L; Maj M
    Acta Psychiatr Scand; 1998 Feb; 97(2):132-8. PubMed ID: 9517907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of self-reported cognitive and motor dysfunction in HIV-positive patients.
    Wilkins JW; Robertson KR; Snyder CR; Robertson WK; van der Horst C; Hall CD
    Am J Psychiatry; 1991 May; 148(5):641-3. PubMed ID: 2018167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropsychological and neurological manifestations of HIV-1 dementia in drug users.
    Handelsman L; Aronson M; Maurer G; Wiener J; Jacobson J; Bernstein D; Ness R; Herman S; Losonczy M; Song IS
    J Neuropsychiatry Clin Neurosci; 1992; 4(1):21-8. PubMed ID: 1627958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apathy, depression, and cognitive performance in HIV-1 infection.
    Castellon SA; Hinkin CH; Wood S; Yarema KT
    J Neuropsychiatry Clin Neurosci; 1998; 10(3):320-9. PubMed ID: 9706540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Auditory event-related potentials in HIV-1 infection: a study in the drug-user risk group.
    Handelsman L; Horvath T; Aronson M; Schroeder M; Jacobson J; Wiener J; Peterson A; Holloway K; Ness R; Herman S
    J Neuropsychiatry Clin Neurosci; 1992; 4(3):294-302. PubMed ID: 1498581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early and late cognitive event-related potentials mark stages of HIV-1 infection in the drug-user risk group.
    Schroeder MM; Handelsman L; Torres L; Dorfman D; Rinaldi P; Jacobson J; Wiener J; Ritter W
    Biol Psychiatry; 1994 Jan; 35(1):54-69. PubMed ID: 8167205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychological performance in HIV-1-infected drug abusers.
    Grassi MP; Perin C; Clerici F; Zocchetti C; Cargnel A; Mangoni A
    Acta Neurol Scand; 1993 Aug; 88(2):119-22. PubMed ID: 8213055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurological and neuropsychological performance in HIV seropositive men without symptoms.
    McAllister RH; Herns MV; Harrison MJ; Newman SP; Connolly S; Fowler CJ; Fell M; Durrance P; Manji H; Kendall BE
    J Neurol Neurosurg Psychiatry; 1992 Feb; 55(2):143-8. PubMed ID: 1538222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective four-year follow-up of neuropsychological function in HIV seropositive and seronegative methadone-maintained patients.
    Silberstein CH; O'Dowd MA; Chartock P; Schoenbaum EE; Friedland G; Hartel D; McKegney FP
    Gen Hosp Psychiatry; 1993 Nov; 15(6):351-9. PubMed ID: 8112557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-sectional phase of the WHO Neuropsychiatric AIDS Study: results of cognitive/neuropsychological assessment.
    Maj M; Starace F
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():370A-371A. PubMed ID: 1498877
    [No Abstract]   [Full Text] [Related]  

  • 19. A longitudinal study of the neuropsychiatric consequences of HIV-1 infection in gay men. I. Neuropsychological performance and neurological status at baseline and at 12-month follow-up.
    Burgess AP; Riccio M; Jadresic D; Pugh K; Catalan J; Hawkins DA; Baldeweg T; Lovett E; Gruzelier J; Thompson C
    Psychol Med; 1994 Nov; 24(4):885-9. PubMed ID: 7892356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early signs of cognitive deficits among human immunodeficiency virus-positive hemophiliacs.
    Riedel RR; Helmstaedter C; Bülau P; Durwen HF; Brackmann H; Fimmers R; Clarenbach P; Miller EN; Böttcher M
    Acta Psychiatr Scand; 1992 Apr; 85(4):321-6. PubMed ID: 1595365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.